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Comment on 'Does a History of Eczema Predict a Future Basal Cell Carcinoma?'
Journal of Investigative Dermatology (2013 Dermatology ( ) 133, 1676 Dermatology ( -1677 doi:10.1038 /jid.2013 published online 21 February 2013 TO THE EDITOR Dyer et al. (2012) examined risk factors for basal cell carcinoma (BCC) in a relatively small cohort of veterans, who participated in the USA Veterans Affairs Topical Tretinoin Chemoprevention Trial. In addition to the usual, wellknown predictors; that is, age, sun sensitivity, a history of prior BCCs, and occupational UV exposure, they found an association with a self-reported history of eczema (atopic dermatitis, AD). In their accompanying editorial, Gamba and Tang (2012) examine competing hypotheses to explain this new association. Because none of the Veterans Affairs (VA) subjects had been treated with calcineurin inhibitors or other immunosuppressives, they then speculate that either the chronic inflammation in AD or other forms of anti-inflammatory therapy for AD, such as topical glucocorticoids or UV phototherapy, could have favored the development of BCCs.
Yet, the BCCs in the VA patients did not occur in previously eczematous sites, suggesting to us that some inherent difference in the structure of the epidermis in subjects at risk for AD could explain the association of AD with an increased prevalence of BCCs. We propose two alternate epidermis-based explanations, either or both of which could be operative. First, assuming that a substantial subgroup of these VA patients have Northern European ancestry, then as many as 40-50% of the subjects with a prior history of AD could bear loss-of-function FLG mutations (Irvine et al., 2011) . Proteolytic degradation of FLG, followed by either enzymatic or non-enzymatic deimination of its constituent amino acids, yields a mixture of polycarboxylic acids that includes trans-urocanic acid (t-UCA) (Scott et al., 1982) , an important endogenous UV-B filter (Finlay-Jones and Hart, 1998) . Reduction in the t-UCA content of stratum corneum (SC) might lead to greater UV-B penetration into the nucleated cell layers with an increased risk of malignant transformation. On the other hand, t-UCA is photo-isomerized by UV-B to cis-UCA (c-UCA), a potent, local immunosuppressive molecule (Kripke, 1984; de Fine Olivarius et al., 1998) . Thus, the possibility that t-UCA deficiency, resulting from reduced FLG, could increase BCCs in this population through greater UV-B penetration must be weighed against the potential benefits of reduced c-UCA generation from t-UCA in a FLGdeficient, tumor environment.
A second, less ambiguous epidermisbased explanation could be the thinner SC that occurs in AD (Cork et al. The final message should be, however, that AD is now generally acknowledged to display a prominent epidermal component, with several of its immunological sequelae occurring downstream of a flawed barrier (Elias et al., 2008 Sattar et al., 2003) . In concert with perforin, GZMB mediates direct and caspase-mediated apoptosis of target cells (Granville, 2010; Ewen et al., 2012) , as well as proteolytic cleavage of autoantigens, creating or exposing autoimmune epitopes that may initiate or propagate the autoimmune process (Darrah and Rosen, 2010) . Meta-analysis of GWAS1, GWAS2, and replication study data for singlenucleotide polymorphisms (SNPs) genotyped in the GZMB region (Jin et al., 2012) showed greatest association with rs8192917-C (P ¼ 5.60 Â 10
